Global Peptide Therapeutics Market is Predicted to Reach US$ 57,166.5 Million by The End of 2027, with a Value of US$ 23,319.3 Million

-
Peptide Therapeutics
Peptide Therapeutics

Peptides are potent signalling molecules that bind to certain cell surface receptors and cause intracellular actions. Over the forecast period, the worldwide Peptide Therapeutics Market is expected to rise due to the rising prevalence of metabolic diseases and cardiovascular disorders (CVDs). According to the American Heart Association's Heart Disease and Stroke Statistics 2018, about 92.1 million adults in the United States suffer from CVD or stroke-related complications.

Furthermore, rising healthcare spending is likely to support market expansion. According to the Centers for Medicare & Medicaid Services (CMS), health spending in the United States is expected to expand at a 5.5 percent annual pace from 2018 to 2027, reaching almost US$ 6.0 trillion. The Global Peptide Therapeutics Market is projected to be hampered by natural peptides' poor chemical and physical stability, as well as their short circulating plasma half-life.

Furthermore, the presence of strict safety requirements is limiting market expansion. Peptide therapies, for example, require a better regulatory framework because they treat various clinical disorders; the regulatory environment is predicted to improve by 2020. Furthermore, R&D in microbiome research is likely to enhance the market for peptide therapies. Researchers from Israel's Chaim Sheba Medical Center stated in January 2020 that high fructose consumption caused metabolic alterations and dysbiosis in rats, and that these changes are likely independent of a specific microbiome composition

The development of novel peptides is projected to provide attractive growth prospects for market players. CohBar, Inc., for example, announced additional preclinical findings in December 2019 that demonstrated the therapeutic potential of a unique CohBar peptide in a preclinical model of Idiopathic Pulmonary Fibrosis (IPF). New platforms for developing next-generation protein or peptide therapies are becoming more popular in the Peptide Therapeutics Market. For example, Xenetic Biosciences, Inc. stated in January 2020 that the data from SHP656 ("PSA-recombinant Factor VIII", "PSA-rFVIII"completed )'s Phase 1/2 clinical research had been published in the journal Haemophilia. PolyXen technology, a patent-protected platform technology for developing next-generation protein or peptide therapies, was used in the study.

Comments

Post a Comment

Popular posts from this blog

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f
Read more

Endometrial Ablation Market Analysis, Industry Scope, Global Opportunity Analysis and Forecast Till 2027

-
Image
Endometrial Ablation Market Endometrial ablation is a procedure used to treat abnormally high uterine bleeding that cannot be managed by medicine by facilitating the destruction of the endometrium, a thin layer of the uterine wall. According to the American College of Obstetrics and Gynecology, Endometrial Ablation Market is not indicated for women who have endometrial diseases, endometrial hyperplasia, uterine cancer, a recent pregnancy, and specific uterine infections (ACOG). There are various endometrial ablation procedures available, including radiofrequency, heated fluid, heated balloon, electrosurgery, freezing, and microwave ablation techniques, depending on the technique and kind of patient being treated. The easy access to recently developed sophisticated ablation technology, convenience of use, shorter treatment times, and outpatient facilities, North America dominates the Endometrial Ablation Market . Endometrial ablation devices would see a sharp rise in global adoption d
Read more

Blowing Agents Market Top Companies, Trends & Growth Factors, and Trend Forecast to 2025

-
Image
Blowing Agents Market The Blowing Agents Market is experiencing substantial growth, driven by the expanding demand from various industries such as construction, automotive, and packaging. Blowing agents are essential in foam production processes, contributing to lightweight and energy-efficient materials. Key market players are continuously investing in research and development to introduce eco-friendly and efficient blowing agents. The rising awareness regarding environmental concerns has led to the adoption of low global warming potential (GWP) and zero ozone depletion potential (ODP) blowing agents. Additionally, stringent regulations and policies promoting sustainable manufacturing practices have further accelerated the demand for environmentally friendly blowing agents. The market is witnessing a trend toward the adoption of innovative technologies to improve production efficiency and product performance. Advanced nucleating agents and microcellular foaming technologies are enhan
Read more